MarketScreener Strategies United Therapeutics Corporation

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
536.12 ^USD	+0.62%		+12.12%	+10.03%

03-11	United Therapeutics Corporation Publishes Full Results Of TETON-2 Phase 3 Clinical Trial For Tyvaso Inhalation Solution	CI
03-09	BETA Technologies Participates In FAA?s eVTOL Integration Pilot Program Across 10 States	CI

June 17, 2025 at 08:39 am

No results for this search

United Therapeutics delivers 18th consecutive quarter of topline growth

June 17, 2025 at 08:39 am